Transcranial ultrasound

Intervention1 paper3 findings

C · W · M · H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper that declares the maker’s interest.

1 lab in 1 country
  • Human trial1

Outcomes

3

MDS 3.0

no changein humans1

1 study
  1. Transcranial ultrasound has no effect on MDS 3.0 in humans.

    “Caregiver-rated outcomes were stable.”

    Human trialcaregiver-ratedUS Pro2000 unfocused ultrasound device5 min three times daily

    Home-administered unfocused transcranial ultrasound in subjective cognitive decline and dementia: an open-label, uncontrolled feasibility pilot study · Frontiers in Aging Neuroscience · 28 Sep 2026

MDS 3.0 →

Inoue battery

no changein humans1

1 study
  1. Transcranial ultrasound has no effect on Inoue battery in humans.

    “and the objective cognitive battery, near ceiling at baseline, did not change.”

    Human trialnear ceiling at baselineUS Pro2000 unfocused ultrasound device5 min three times daily

    Home-administered unfocused transcranial ultrasound in subjective cognitive decline and dementia: an open-label, uncontrolled feasibility pilot study · Frontiers in Aging Neuroscience · 28 Sep 2026

Inoue battery →

CESD-5

downin humans1

1 study
  1. Transcranial ultrasound decreases CESD-5 in humans.

    “Among self-administered participants, depression (CESD-5) declined significantly ( p _FDR = 0.016)”

    Human trialin self-administered participantsUS Pro2000 unfocused ultrasound device5 min three times daily

    Home-administered unfocused transcranial ultrasound in subjective cognitive decline and dementia: an open-label, uncontrolled feasibility pilot study · Frontiers in Aging Neuroscience · 28 Sep 2026

CESD-5 →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01